DR. PEN® Ultima A6 Professional Microneedling System | Automated CIT Device

Short Description

A clinical-grade, dual-powered automated percutaneous collagen induction therapy (CIT) system engineered for medical dermatology and professional aesthetic clinics. Powered by a high-torque rotary motor generating up to 15,000 RPM across 5 speed levels, the Dr. Pen® Ultima A6 features a micro-calibrated needle depth dial ranging from 0.25 mm to 2.5 mm with a secure bayonet-mount locking mechanism. Equipped with two interchangeable, rechargeable lithium-ion battery modules (plus corded AC capability) and precision surgical-grade 316 stainless steel needle cartridges (12-pin, 36-pin, 42-pin, and Nano), the device delivers high-density vertical transdermal micro-punctures to trigger controlled wound-healing cascades, remodel atrophic scars, improve transdermal meso-infusion by up to 80%, and induce de novo neocollagenesis with minimal epidermal shearing.

Detailed Description & Mechanism of Action

The Dr. Pen® Ultima A6 is an automated micro-needling device designed to deliver uniform, high-density micro-injuries to the epidermal and dermal layers. Unlike manual dermarollers that enter and exit the skin at an angle—causing lateral tissue micro-tears, epidermal track marks, and prolonged inflammation—the Ultima A6 utilizes a direct reciprocating piston mechanism that drives needles vertically at a perpendicular 90° angle.

The system operates across two complementary clinical mechanisms:

Automated Vertical Micro-Stamping (0.25–2.5 mm)
  ├── 1. Physical Disruption of Stratum Corneum ──► Bypass Lipid Barrier ──► Enhanced Meso/PDRN Infusion (>80%)
  └── 2. Controlled Dermal Micro-Trauma ──► Platelet Activation (PDGF, TGF-β, FGF) ──► Type I/III Neocollagenesis

1. Percutaneous Collagen Induction Therapy (CIT):

   • Phase I (Hemostasis & Inflammation, Days 1–3): The mechanical micro-punctures disrupt dermal capillary loops and trigger localized platelet aggregation. Platelet degranulation releases essential chemotactic factors, including Platelet-Derived Growth Factor (PDGF), Transforming Growth Factor-beta (TGF-$\beta$), and Fibroblast Growth Factor (FGF). Neutrophils and macrophages clear debris while releasing interleukins that recruit undifferentiated mesenchymal stem cells.

   • Phase II (Tissue Proliferation, Days 4–21): Recruited dermal fibroblasts migrate into the micro-channels, synthesizing an immature provisional extracellular matrix composed predominantly of Type III collagen, glycosaminoglycans (GAGs), and fibronectin. Microvascular angiogenesis is concurrently stimulated via VEGF release.

   • Phase III (Tissue Remodeling & Maturation, Months 1–12): Matrix metalloproteinases (MMPs) gradually replace pliable Type III collagen with dense, highly organized bundles of cross-linked Type I collagen along lines of mechanical tension. This restores tensile strength to the dermis, tightens lax tissue, and elevates the fibrotic floor of atrophic scars.

2. High-Yield Transdermal Microporation (Active Drug Delivery Synergy):

   • The stratum corneum represents the primary rate-limiting barrier to transdermal delivery, restricting the penetration of molecules larger than 500 Daltons.

   • By puncturing thousands of transient micro-channels per second into the viable epidermis and papillary dermis, the A6 increases the transdermal delivery and intracellular bioavailability of topically applied regenerative solutions—such as Salmon PDRN (e.g., Gevinex, Remedium, Rejuran), non-cross-linked Hyaluronic Acid, Exosomes, and Peptide complexes—by up to 80% to 85%.

Clinical Indications & Treatment Applications

• Atrophic Scars & Cutaneous Fibrous Remodeling:

  • Post-acne scars: Rolling scars, shallow boxcar scars, and base remodeling of ice-pick scars

  • Post-surgical, traumatic, and post-cesarean hypotrophic scars

  • Body striae: Post-pregnancy abdominal Striae Rubrae (early erythematous) and Striae Albae (chronic pale/fibrotic)

• Facial Photoaging, Laxity & Rhytids:

  • Perioral barcode lines (Smoker’s rhytids) and dynamic lateral canthal lines (Crow’s feet)

  • Superficial forehead wrinkles, glabellar lines, and midface elastosis

  • Accordion smile lines and cervical horizontal neck rings

• Epidermal Texture & Dyschromia:

  • Enlarged pores (follicular infundibular widening) and uneven micro-relief

  • Solar lentigines, dull/sallow complexion, and photo-induced hyperpigmentation

  • Melasma management (when combined with transdermal Tranexamic Acid / Glutathione cocktails at superficial depths of 0.25–0.5 mm)

• Trichology & Scalp Alopecia Protocols:

  • Androgenetic alopecia (male and female pattern hair loss)

  • Telogen effluvium and thinning hairline maintenance

  • Micro-channeling prior to topical Minoxidil, Gevinex Hair Treat, Copper Peptides, or Exosome scalp serums

Key Device Engineering & Operational Advantages

• Dual-Power Operating Architecture (Corded / Cordless Flexibility):

  • Supplied with two dedicated 500 mAh rechargeable lithium-ion battery modules, ensuring zero operational interruption between back-to-back clinic appointments (one battery charges in the external dock while the other operates in the handpiece).

  • Includes an AC power adapter module that converts the handpiece into an uninterrupted, direct corded system for extended multi-area procedures (e.g., full abdomen striae or multiple body zones).

• Aircraft-Grade Matte Aluminum Alloy Casing:

  • Robust, ergonomic metal chassis that resists vibration fatigue, balances hand-weight distribution, and withstands routine medical-grade disinfectant wipes (quaternary ammonium, chlorhexidine, 70% isopropyl alcohol).

• Micro-Calibrated Stepless Depth Control (0.25 mm to 2.5 mm):

  • Precision knurled depth dial enables continuous, real-time needle adjustment during the procedure, allowing the clinician to transition seamlessly from delicate 0.25 mm periorbital settings to 2.0–2.5 mm deep scar settings without changing cartridges.

• Stable Bayonet-Mount Coupling:

  • The proprietary bayonet-locking cartridge slot prevents wobble, slippage, or needle dislodgement under high axial friction, maintaining straight vertical vector entry.

• High-Torque Rotary Coreless Motor:

  • Maintains stable RPM without stalling or dragging when contacting dense, fibrotic scar tissue or thick scalp skin.